**Question:** Rate limiting step in porphyrine synthesis -

A. Uroporphyrinogen III synthase
B. Uroporphyrinogen III oxidase
C. Uroporphyrinogen III decarboxylase
D. Heme biosynthesis pathway

**Core Concept:** In the heme biosynthesis pathway, porphyrins are a group of macrocyclic compounds that serve as the core structure for heme, a vital component of hemoglobin, myoglobin, and cytochromes. The pathway consists of ten enzymes, and the rate limiting step controls the overall rate of heme synthesis.

**Why the Correct Answer is Right:** The correct answer is **C. Uroporphyrinogen III decarboxylase**. This enzyme catalyzes the decarboxylation of uroporphyrinogen III to coproporphyrinogen III, which is the first committed step in heme biosynthesis. Since this reaction is rate-limiting, any perturbation in this step will significantly affect the overall heme production.

**Why Each Wrong Option is Incorrect:**

A. **Uroporphyrinogen III synthase (Option A)**: This enzyme is responsible for the formation of uroporphyrinogen III from porphobilinogen and coprostanol. The correct answer (C) is not related to the formation of uroporphyrinogen III but to its decarboxylation.

B. **Uroporphyrinogen III oxidase (Option B)**: This enzyme catalyzes the oxidation of uroporphyrinogen III to coproporphyrinogen III, which is downstream of the rate-limiting step. Therefore, this step is not rate-limiting and correct answer (C) is not related to this enzyme.

D. **Heme biosynthesis pathway (Option D)**: This option refers to the entire heme biosynthesis pathway, not a specific enzyme involved in rate-limiting step.

**Clinical Pearl:** Heme biosynthesis is crucial for normal cellular function, and any deficiency in the pathway can lead to various clinical conditions. For instance, deficiency in the enzyme **C. Uroporphyrinogen III decarboxylase** can result in a rare genetic disorder called porphyrias, which is characterized by excessive accumulation of porphyrins and their precursors in the body. These disorders include porphyrias variegate, acute intermittent porphyria, and erythropoietic porphyria. Understanding the rate-limiting steps in heme biosynthesis is essential for diagnosing and managing these conditions.